Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Cirrhosis

  Free Subscription


01.11.2021

4 BMC Gastroenterol
1 Dig Dis Sci
1 Gastroenterology
5 Hepatology
1 J Hepatol
3 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Gastroenterol

  1. ZHANG Y, Hu X, Chang J, Chen J, et al
    The liver steatosis severity and lipid characteristics in primary biliary cholangitis.
    BMC Gastroenterol. 2021;21:395.
    PubMed         Abstract available

  2. PINYOPORNPANISH K, Khoudari G, Saleh MA, Angkurawaranon C, et al
    Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study.
    BMC Gastroenterol. 2021;21:394.
    PubMed         Abstract available

  3. LI F, Lei F, Wen C, Ge Q, et al
    Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus.
    BMC Gastroenterol. 2021;21:391.
    PubMed         Abstract available

  4. NABABAN SHH, Mansjoer A, Fauzi A, Gani RA, et al
    Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia.
    BMC Gastroenterol. 2021;21:392.
    PubMed         Abstract available


    Dig Dis Sci

  5. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    PubMed         Abstract available


    Gastroenterology

  6. LEE TH, Roper J, King L
    MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    PubMed         Abstract available


    Hepatology

  7. CHEN L, Guo P, Li W, Fang F, et al
    Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis.
    Hepatology. 2021;73:1551-1569.
    PubMed         Abstract available

  8. SCHULTHEISS C, Simnica D, Willscher E, Oberle A, et al
    Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis.
    Hepatology. 2020 Jul 21. doi: 10.1002/hep.31473.
    PubMed         Abstract available

  9. LEUNG KK, James PD, Jaberi A, Hirschfield GM, et al
    Esophageal Stenting as Bridge Therapy to Direct Intrahepatic Portocaval Shunt for Refractory Variceal Bleeding.
    Hepatology. 2020 Aug 11. doi: 10.1002/hep.31519.
    PubMed         Abstract available

  10. SONG Z, Chen W, Athavale D, Ge X, et al
    Osteopontin Takes Center Stage in Chronic Liver Disease.
    Hepatology. 2021;73:1594-1608.
    PubMed         Abstract available

  11. MANCUSO A
    Portal vein thrombosis in cirrhosis: the issue of treatment.
    Hepatology. 2021 Oct 28. doi: 10.1002/hep.32216.
    PubMed         Abstract available


    J Hepatol

  12. LOGLIO A, Ferenci P, Uceda Renteria SC, Tham CYL, et al
    Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis.
    J Hepatol. 2021 Oct 23. pii: S0168-8278(21)02119.
    PubMed         Abstract available


    N Engl J Med

  13. SANYAL AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, et al
    Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2021;385:1559-1569.
    PubMed         Abstract available

  14. FRANCQUE SM, Bedossa P, Ratziu V, Anstee QM, et al
    A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
    N Engl J Med. 2021;385:1547-1558.
    PubMed         Abstract available

  15. CHANDRA A, Bhattacharjee MS
    Kayser-Fleischer Rings in Wilson's Disease.
    N Engl J Med. 2021;385:e46.
    PubMed        


    PLoS One

  16. ZHANG X, Heredia NI, Balakrishnan M, Thrift AP, et al
    Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    PLoS One. 2021;16:e0252164.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: